US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist
  • 2.0700
  • -0.1800-8.00%
Close Dec 13 16:00 ET
  • 2.0200
  • -0.0500-2.42%
Post 19:58 ET
424.23MMarket Cap3.29P/E (TTM)

Taysha Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-20.42%-21.62M
-14.58%-21.5M
1.92%-19.8M
17.39%-73.02M
-209.55%-16.12M
37.70%-17.95M
43.73%-18.77M
50.69%-20.19M
24.48%-88.39M
136.54%14.71M
Net income from continuing operations
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
Operating gains losses
---75K
---195K
--337K
--36.95M
---63.51M
----
----
----
----
----
Depreciation and amortization
-11.18%294K
-6.12%322K
-1.81%325K
16.98%1.37M
1.10%366K
19.49%331K
25.64%343K
27.31%331K
138.21%1.17M
73.21%362K
Other non cash items
-55.09%1.38M
-93.92%247K
-75.47%105K
167.01%9.27M
198.26%1.71M
399.35%3.07M
666.42%4.06M
-75.58%428K
-65.76%3.47M
-80.46%574K
Change In working capital
20.20%-5.88M
-437.94%-4.28M
105.96%298K
-197.27%-18.01M
-117.11%-4.85M
3.57%-7.37M
81.07%-796K
-345.43%-5M
-35.40%18.52M
1,298.37%28.33M
-Change in prepaid assets
-121.18%-741K
-9.57%822K
-73.25%-693K
187.88%6.01M
1,754.63%2M
84.16%3.5M
575.92%909K
-247.60%-400K
162.12%2.09M
105.90%108K
-Change in payables and accrued expense
45.25%-3.35M
-678.55%-3.99M
3,938.53%4.4M
49.95%-8.57M
39.13%-3.25M
35.83%-6.12M
117.19%690K
-93.82%109K
-153.48%-17.13M
-238.29%-5.33M
-Change in other working capital
62.33%-1.79M
53.57%-1.11M
27.52%-3.41M
-146.04%-15.45M
---3.6M
---4.75M
---2.4M
---4.71M
--33.56M
----
Cash from discontinued investing activities
Operating cash flow
-20.42%-21.62M
-14.58%-21.5M
1.92%-19.8M
17.39%-73.02M
-209.55%-16.12M
37.70%-17.95M
43.73%-18.77M
50.69%-20.19M
24.48%-88.39M
136.54%14.71M
Investing cash flow
Cash flow from continuing investing activities
99.00%-35K
-518.75%-201K
96.41%-140K
70.51%-7.35M
99.58%-10K
-15.56%-3.49M
100.59%48K
65.87%-3.9M
-15.66%-24.93M
72.18%-2.37M
Net PPE purchase and sale
---35K
-518.75%-201K
96.41%-140K
81.24%-3.87M
99.26%-17K
--0
100.61%48K
53.72%-3.9M
-34.73%-20.62M
72.08%-2.31M
Net intangibles purchase and sale
----
----
----
17.65%-3.5M
--0
----
----
----
32.00%-4.25M
--0
Net other investing changes
----
----
----
127.87%17K
--7K
----
----
----
---61K
----
Cash from discontinued investing activities
Investing cash flow
99.00%-35K
-518.75%-201K
96.41%-140K
70.51%-7.35M
99.58%-10K
-15.56%-3.49M
100.59%48K
65.87%-3.9M
-15.66%-24.93M
72.18%-2.37M
Financing cash flow
Cash flow from continuing financing activities
-95.31%6.6M
18,591.78%70.47M
94.05%-22K
161.81%136.39M
-110.30%-4.25M
136,637.86%140.63M
-96.60%377K
-245.79%-370K
33.30%52.1M
352.85%41.23M
Net issuance payments of debt
----
----
----
---3.45M
----
----
----
----
--0
----
Net common stock issuance
-95.27%6.66M
----
----
164.42%140.79M
-101.02%-423K
--140.71M
----
----
--53.24M
--41.6M
Proceeds from stock option exercised by employees
250.00%63K
--0
-48.00%26K
-73.12%68K
--0
126.47%18K
--0
-81.95%50K
--253K
--0
Net other financing activities
-30.93%-127K
89.43%-13K
88.57%-48K
27.50%-1.02M
-0.81%-375K
-177.14%-97K
79.80%-123K
-9.38%-420K
-60.18%-1.4M
---372K
Cash from discontinued financing activities
Financing cash flow
-95.31%6.6M
18,591.78%70.47M
94.05%-22K
161.81%136.39M
-110.30%-4.25M
136,637.86%140.63M
-96.60%377K
-245.79%-370K
33.30%52.1M
352.85%41.23M
Net cash flow
Beginning cash position
267.44%175.34M
91.61%126.58M
61.89%146.54M
-40.35%90.52M
351.82%166.92M
-30.72%47.72M
-33.45%66.06M
-40.35%90.52M
-39.61%151.74M
-80.70%36.94M
Current changes in cash
-112.63%-15.06M
365.85%48.76M
18.38%-19.96M
191.51%56.02M
-138.03%-20.38M
473.27%119.2M
39.65%-18.34M
53.40%-24.46M
38.48%-61.22M
235.04%53.57M
End cash Position
-3.97%160.29M
267.44%175.34M
91.61%126.58M
61.89%146.54M
61.89%146.54M
351.82%166.92M
-30.72%47.72M
-33.45%66.06M
-40.35%90.52M
-40.35%90.52M
Free cash flow
-0.94%-21.65M
-15.95%-21.71M
17.22%-19.94M
29.02%-80.39M
-230.08%-16.13M
32.61%-21.45M
54.86%-18.72M
54.01%-24.09M
18.28%-113.26M
125.43%12.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -20.42%-21.62M-14.58%-21.5M1.92%-19.8M17.39%-73.02M-209.55%-16.12M37.70%-17.95M43.73%-18.77M50.69%-20.19M24.48%-88.39M136.54%14.71M
Net income from continuing operations 78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M
Operating gains losses ---75K---195K--337K--36.95M---63.51M--------------------
Depreciation and amortization -11.18%294K-6.12%322K-1.81%325K16.98%1.37M1.10%366K19.49%331K25.64%343K27.31%331K138.21%1.17M73.21%362K
Other non cash items -55.09%1.38M-93.92%247K-75.47%105K167.01%9.27M198.26%1.71M399.35%3.07M666.42%4.06M-75.58%428K-65.76%3.47M-80.46%574K
Change In working capital 20.20%-5.88M-437.94%-4.28M105.96%298K-197.27%-18.01M-117.11%-4.85M3.57%-7.37M81.07%-796K-345.43%-5M-35.40%18.52M1,298.37%28.33M
-Change in prepaid assets -121.18%-741K-9.57%822K-73.25%-693K187.88%6.01M1,754.63%2M84.16%3.5M575.92%909K-247.60%-400K162.12%2.09M105.90%108K
-Change in payables and accrued expense 45.25%-3.35M-678.55%-3.99M3,938.53%4.4M49.95%-8.57M39.13%-3.25M35.83%-6.12M117.19%690K-93.82%109K-153.48%-17.13M-238.29%-5.33M
-Change in other working capital 62.33%-1.79M53.57%-1.11M27.52%-3.41M-146.04%-15.45M---3.6M---4.75M---2.4M---4.71M--33.56M----
Cash from discontinued investing activities
Operating cash flow -20.42%-21.62M-14.58%-21.5M1.92%-19.8M17.39%-73.02M-209.55%-16.12M37.70%-17.95M43.73%-18.77M50.69%-20.19M24.48%-88.39M136.54%14.71M
Investing cash flow
Cash flow from continuing investing activities 99.00%-35K-518.75%-201K96.41%-140K70.51%-7.35M99.58%-10K-15.56%-3.49M100.59%48K65.87%-3.9M-15.66%-24.93M72.18%-2.37M
Net PPE purchase and sale ---35K-518.75%-201K96.41%-140K81.24%-3.87M99.26%-17K--0100.61%48K53.72%-3.9M-34.73%-20.62M72.08%-2.31M
Net intangibles purchase and sale ------------17.65%-3.5M--0------------32.00%-4.25M--0
Net other investing changes ------------127.87%17K--7K---------------61K----
Cash from discontinued investing activities
Investing cash flow 99.00%-35K-518.75%-201K96.41%-140K70.51%-7.35M99.58%-10K-15.56%-3.49M100.59%48K65.87%-3.9M-15.66%-24.93M72.18%-2.37M
Financing cash flow
Cash flow from continuing financing activities -95.31%6.6M18,591.78%70.47M94.05%-22K161.81%136.39M-110.30%-4.25M136,637.86%140.63M-96.60%377K-245.79%-370K33.30%52.1M352.85%41.23M
Net issuance payments of debt ---------------3.45M------------------0----
Net common stock issuance -95.27%6.66M--------164.42%140.79M-101.02%-423K--140.71M----------53.24M--41.6M
Proceeds from stock option exercised by employees 250.00%63K--0-48.00%26K-73.12%68K--0126.47%18K--0-81.95%50K--253K--0
Net other financing activities -30.93%-127K89.43%-13K88.57%-48K27.50%-1.02M-0.81%-375K-177.14%-97K79.80%-123K-9.38%-420K-60.18%-1.4M---372K
Cash from discontinued financing activities
Financing cash flow -95.31%6.6M18,591.78%70.47M94.05%-22K161.81%136.39M-110.30%-4.25M136,637.86%140.63M-96.60%377K-245.79%-370K33.30%52.1M352.85%41.23M
Net cash flow
Beginning cash position 267.44%175.34M91.61%126.58M61.89%146.54M-40.35%90.52M351.82%166.92M-30.72%47.72M-33.45%66.06M-40.35%90.52M-39.61%151.74M-80.70%36.94M
Current changes in cash -112.63%-15.06M365.85%48.76M18.38%-19.96M191.51%56.02M-138.03%-20.38M473.27%119.2M39.65%-18.34M53.40%-24.46M38.48%-61.22M235.04%53.57M
End cash Position -3.97%160.29M267.44%175.34M91.61%126.58M61.89%146.54M61.89%146.54M351.82%166.92M-30.72%47.72M-33.45%66.06M-40.35%90.52M-40.35%90.52M
Free cash flow -0.94%-21.65M-15.95%-21.71M17.22%-19.94M29.02%-80.39M-230.08%-16.13M32.61%-21.45M54.86%-18.72M54.01%-24.09M18.28%-113.26M125.43%12.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List